A current challenge in the era of genome-wide studies is to determine the responsible genes and mechanisms underlying newly identified loci. Screening of the plasma proteome by high-throughput mass spectrometry (MALDI-TOF MS) is considered as a promising approach for identification of metabolic and disease processes. Therefore, plasma proteome screening might be particularly useful for identifying responsible genes when combined with analysis of variation in the genome. Here, we describe a proteomic quantitative trait locus (pQTL) study of plasma proteome screens in an F2 intercross of 
Introduction
The central dogma of molecular biology states that sequence information is carried from DNA to RNA to protein (Crick 1970) and it is commonly accepted that differences in protein function or abundance are in most cases responsible for phenotypic differences and susceptibility to disease. To date, mapping complex traits with global gene expression -designated expression quantitative trait loci (eQTL) mapping-has been remarkably successful in identifying the underlying molecular mechanisms (reviewed by (Cookson et al. 2009)) . That approach has been greatly facilitated by advances in expression array technology. However, mRNA levels explain only around 40% of the variability in protein levels (Schwanhausser et al. 2011) . Therefore, using the proteome as a surrogate, which might be more closely related to the phenotype level, may provide novel insights into genetic regulation of certain phenotypes ( Figure S1 ).
The global analysis of proteins has been exceedingly difficult in the past (Gstaiger and Aebersold 2009 ) and only few studies have previously attempted a combined analysis of proteome-wide and genome-wide data: An approach in yeast BY4716xRM11-1a segregants (n=98) successfully identified genetically determined proteins using labelfree liquid chromatography-tandem mass spectrometry (LC-MS/MS) (Foss et al. 2007 ).
In mice, Klose et al have investigated brain proteome expression in 64 N2 progeny of a C57BL/6 x SPR backcross using two-dimensional gel electrophoresis (Klose et al. 2002) . A recent study performed comparative analyses of proteome and transcriptome variation in liver from 97 inbred and recombinant inbred mice of the Hybrid Mouse Diversity Panel using reference-based isotope labelling (Ghazalpour et al. 2011). 5 However, these techniques are labor intensive, difficult to standardize and therefore have limited suitability for larger sets of individuals.
For high-throughput proteomic screening of plasma, techniques using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) with reversed phase sample processing have been developed (Villanueva et al. 2006 ). These technologies have been adapted for clinical application and blood plasma is used as an easily accessible primary source (Baumann et al. 2005) . Plasma comes in contact with most tissues and may therefore be considered as a mirror of metabolic and disease processes (Anderson and Anderson 2002) .
The aim of the present study was to investigate whether combining plasma proteome screening with genetic screening in a large segregating intercross of 455 F2 mice ( Figure 1A , Figure S1 ) may provide novel information about genetic regulation of distinct components of the plasma. (Teupser et al. 2006) . Plasma was isolated immediately after blood drawing and stored at -80°C until analysis. Blood samples from additional parental mice were used for hematology and measurement of plasma parameters.
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Materials and Methods
Mice
MALDI-TOF mass spectrometry
Plasma (20 µL) was fractionated using ClinProt TM micro particle beads with hydrophobic interaction properties (MB-HIC C8; Bruker Daltonics) and a ClinPro Tools liquid handling robot (Bruker Daltonics) (Baumann et al. 2005) . For proteome analysis, a MALDI-TOF mass spectrometer (Autoflex; Bruker Daltonics) in linear positive mode with the following settings was used: Ion source 1, 20 kV; ion source 2, 18.50 kV; lens, 9.00 kV; pulsed ion extraction, 120 ns; nitrogen pressure, 2.5 x 10 -5 Pa. Samples were ionized by irradiation with a nitrogen laser (A = 337 nm) operating at 50 Hz. For matrix suppression, a high gating factor with signal suppression up to 500 Da was used. Mass calibration was performed with a calibration mixture of peptides and proteins in a mass range of 800 -7 fold MALDI-spotting). For each spot, 300 spectra were acquired using 30 laser shots at 10 different spot positions. To increase the detection sensitivity, excess matrix was removed with 6 shots at a laser power of 45% before data acquisition at about 25%. All signals with a signal-to-noise (S/N) ratio ≥ 3 in a mass range of 800 -10 000 Da were recorded using the AutoXecute tool of the flexControl acquisition software (Bruker Daltonics). Samples for MALDI-TOF/TOF analysis were fractionated as described above and analyzed with an Autoflex 2 TOF/TOF instrument (Bruker Daltonics). Peptide identification was performed using Mascot software (Perkins et al. 1999) .
Processing of MALDI data
Data of raw mass spectrometry spectra were analyzed by two different data processing techniques ( Figure S2 ):
1) Area under the curve (AUC)-based analysis:
Data analysis was performed using ClinProTools TM software (Bruker Daltonics). In brief, baseline reduction was performed using the Convex hull baseline reduction model (Toussaint and Avis 1980) and spectra were normalized to total ion current (TIC) of each spectrum. Using a total average spectrum calculated from the preprocessed individual spectra (Morris et al. 2005) Figure S2A , left). These are referred to as 'reference peaks', and the AUCs of these peaks were calculated in the F2 spectra after normalization.
Subsequently, these AUCs were used as phenotypes for QTL mapping. 
Blood analysis and clinical chemistry
For determination of blood cell parameters (absolute count, hemoglobin, hematocrit, MCV, MCH, MCHC) an automated hematology analyzer (Sysmex) was used. Osmotic resistance of erythrocytes was determined by diluting 10 µL of whole blood in 1 mL 0.3-0.6% NaCl solution increasing 0.02% per step. After 2 h incubation at room temperature, hemoglobin was spectrophotometrically determined in the supernatants (Sysmex).
Lipoproteins were isolated by sequential ultracentrifugation and cholesterol was determined as previously described (Teupser et al. 2004) . For high density lipoprotein (HDL) depletion experiments, lipoprotein fractions were isolated as described (Teupser et al. 2004 ) and analysed by mass spectrometry. For spiking experiments, isolated HDL was added to previously HDL-depleted plasma of FVB.Ldlr -/-. Plasma haptoglobin levels were determined using an ELISA according to the manufacturer's instructions (USCN Life Science).
LC-MS/MS analysis of Apoa2 in HDL
HDL fractions from FVB.Ldlr -/-and B6.Ldlr -/-mice were acetone precipitated and redissolved in 6 M urea and measurements were performed essentially as described (Muller et al. 2010) . The protein amount was determined by Bradford assay, 100 µg of protein were desalted using Amicon filters (MWCO 10 kDa) and separated in 10-50 kDa fractions using a Gelfree® 8100 Fractionation System (Protein Discovery, San Diego, 
DNA sequencing
Mouse hemoglobin alpha transcripts Hba-a1 (NM_008218, located at 32.196.489-32.197.303 bp and 32.183.672-32184486 bp) and Hba-a2 (NM_001083955, located at 32.196.492-32.197.310 bp and 32.183.675-32.184 .493 bp) were sequenced using the following primers-homologous with sequence variants either in the proximal or distal
5'-CATTAAGGAGTTCACTCCCTGAGAGGG-3'. PCR reactions were prepared using TaqPolymerase (Roche) and sequencing was performed with an automated DNA sequencer at the Core Unit for DNA Technologies, Medical Faculty, University Leipzig (ABI 3100 Genetic Analyzer, Applied Biosystems).
RNA isolation and quantitative flourogenic RT-PCR
Total RNA isolation from livers of 393 F2 mice, reverse transcription into cDNA and quantitative fluorogenic RT-PCR of the house-keeping gene beta-actin (BA) was performed as described (Holdt et al. 2008) . Primers and probe for Apoa2 (NM_013474)
were: 5'-primer 5'-CACAGAATCGCAGCACTGTT-3'; 3'-primer 5'-CGTCTGCCTGTCTCTTAACCA-3'; probe 5'-FAM-CCTAGGCCATAGTCTGCCATCATGAAGCTG-TAMRA-3'. All measurements were performed in quadruplicates, absolute copy numbers were determined using 11 plasmid dilution series containing the target sequence. Expression levels were normalized to BA as a house-keeping gene.
Statistical analysis
All data are given as mean ± standard error. All samples were normally distributed as assessed with the Kolmogorov-Smirnov test implemented in PRISM statistical software (GraphPad). Comparison of multiple groups was done using ANOVA and Tukey was performed as post-test. Comparison of two groups was done using the t-test. QTL mapping of proteome data, Apoa2 mRNA expression and HDL phenotypes of F2 animals was performed using R/qtl (Broman et al. 2003) . Genotypes of F2 mice (177 markers per mouse) were available from our previous work (Teupser et al. 2006) .
Significance was determined by empirical permutation test with 1000 permutations of the entire datasets using the scanone function implemented in R/qtl (Broman et al. 2003) .
Results
Proteomic QTL (pQTL) mapping
Combining high-throughput proteomic screening with genome-wide analysis, we show that distinct components of the plasma proteome are strongly regulated by genetic factors. Coefficients of variations of measurements for individual samples were on average around 20% ( Figure S3 ), providing evidence for the reproducibility of measurements. Proteomic spectra were obtained from plasma of 455 mice of an F2
intercross between B6.Ldlr -/-and FVB.Ldlr -/-mice ( Figure 1A ). This intercross had been originally designed to identify loci of atherosclerosis susceptibility (Teupser et al. 2006) .
Spectra from parental mice ( Figure 1B ) showed significant strain-dependent differences in peak intensities ( Figure 1C ). Major peaks were retained through F1 ( Figure 1D ) and F2 generations ( Figure 1E ), indicating that genetic inheritance is reflected in the plasma.
A total of 176 peptides were defined where peak-heights differed in normalized spectra of parental F0 mice ( Figure S2A ). The area under the curve (AUC) of these peaks was then calculated in normalized spectra of 455 F2 mice. The correlation structure between mass peaks is shown in Figure S4 . To identify potential genetic effects, pQTL mapping was performed using a set of 177 polymorphic microsatellite markers evenly distributed across each animal's genome (Teupser et al. 2006) . The resulting LOD score matrix provided evidence for genetic regulation of 69 of the 176 previously detected peaks ( Figure 2A ) with LOD scores ≥ 5.35 reaching genome-wide significance (determined by permutation testing (n=1000) at a P-value of 0.01 after Bonferroni-correction for 176 proteome phenotypes). Table 1 summarizes 7 pQTLs with particularly high LOD scores (> 20) , which mapped to chromosomes (Chr) 1, 7, 11 and 17, respectively. These 13 pQTLs explained between 21 and 39% of the variance of the underlying protein mass intensities (Table 1) . A parallel analysis based on binning of normalized proteomic F2 spectra every 5 m/z ( Figure S2B ) led to similar results and showed 87% overlap with the peak-based analysis ( Figure 2B ). Differences between the results of the two methods might in part be related to pre-processing of raw spectra, which involved background subtraction in the AUC-based analysis, potentially leading to inflation of LOD-scores for small signals. Of 7 top pQTLs identified in the AUC analysis, 6 were validated through the m/z-based analysis with comparable effects sizes (Table 1) . In further support, two of the most significant pQTLs, located at D1Mit111 and D11Mit151, (Table 1) , were also concordant with major peak differences between parental strains at m/z 8713 and m/z 3494, respectively ( Figure 1C ). Importantly, information added by pQTL mapping now also indicated the genetic basis for their differential regulation. We thus attempted to identify underlying proteins and genetic regulation at these two strongest pQTLs in the following work.
Genetic variants in haemoglobin alpha (Hba) are responsible for the 3494 m/z locus on Chr11
Here, we show that the 3494 m/z peak represents a fragment of Hba and genetic variation in Hba leads to increased release of free hemoglobin from red blood cells 
6). Genotyping a SNP within
Hba significantly improved the LOD score to 32.3 ( Figure 3A) , thereby confirming the peak LOD at the physical position of the Hba genes. These data provided strong evidence that genetic variation at Hba was responsible for different abundance of free hemoglobin in plasma. The hemoglobin fragment was less abundant in F2 mice carrying the FVB.Ldlr -/-allele at Hba compared to B6.Ldlr -/-( Figure 3B ), a finding also observed in parental FVB.Ldlr -/-and B6.Ldlr -/-mice ( Figure 3C ). Differences in hemoglobin concentrations were also confirmed using a photo-spectrometric assay for free hemoglobin in plasma ( Figure 3D ). These data suggested increased hemolysis of RBC from B6.Ldlr -/-compared to FVB.Ldlr -/-mice. We therefore tested several RBC parameters, showing that total hemoglobin, numbers of RBC, hematocrit and mean corpuscular volume ( Figure 3E-H Figure 3J ).
Remarkably, these RBC phenotype differences in susceptibility to hemolysis and changes in osmotic resistance are well compatible with changes seen in human alpha thalassemia which is caused by genetic variation in HBA (for review see (Weatherall 2004) Figure 3K , Figure S5A ). One of these variants was located within the N-terminus of Hba, which was also contained in a fragment detected at the m/z 3494 peak and subsequently identified by MALDI TOF/TOF. The FVB variant would lead to a theoretical mass increase of 42 Da compared to B6. FVB also had a prominent mass peak at m/z 3536 in addition to the peak at 3494, confirming these considerations ( Figure S5B ). The two peaks at m/z 3494 and m/z 3526 in FVB.Ldlr -/-therefore represent the amino-acid difference between fragments from the two duplicated Hba genes at 32.20 and 32.18 Mb, respectively ( Figure 3K ). To assess potential effects of the identified variants on protein conformation and heme-binding, we modelled the identified variants onto the mouse Hba structure (protein data bank identification: 3HRW). Indeed, the three identified variants were sterically close to the heme molecule incorporated in the Hba chain ( Figure 3L , Figure S5C ) and might therefore be responsible for stability of the hemoglobin complex.
In summary, we show that the lower abundance of the m/z 3494 fragment of Hba in FVB.Ldlr -/-was due to a combined effect of only 2 copies of the gene coding for this peptide, rather than 4 copies in the B6.Ldlr -/-strain as well as lower free haemoglobin concentrations in FVB.Ldlr -/-( Figure 3D ). The latter is was caused by genetic variation rendering RBC from FVB.Ldlr -/-mice more stable than from B6.Ldlr -/-( Figure 3J ), leading to decreased release of free hemoglobin into plasma in vitro and in vivo.
Variation in the apolipoprotein A2 (apoA2) gene is associated with the 8713 m/z locus on Chr1
We provide evidence that variation in Apoa2 is responsible for the m/z 8713 pQTL ( Figure 4A ) and differences in HDL-cholesterol at Chr1. The variation in abundance observed in the genotypic means at D1Mit111 for m/z 8713 in the F2 ( Figure 4B) matched that observed in the parentals ( Figure 4C ). An important observation was that the QTL at m/z 8713 co-segregated with an almost identically shaped QTL for HDLcholesterol ( Figure 4D ) suggesting that m/z 8713 was related to HDL-cholesterol. This was corroborated by comparable genotypic effects for HDL-cholesterol at D1Mit111 in the F2 ( Figure 4E ) and in the parentals ( Figure 4F ). An HDL-QTL at distal Chr1 has been described in multiple mouse crosses and was designated Hdlq5. The QTL has only been detected in crosses where parental strains had an A V change at position 61 of the Apoa2 gene (Doolittle et al. 1990; Wang et al. 2004) . Five alleles of Apoa2 have been identified (Wang et al. 2004 ). B6.Ldlr 
Discussion
In the present work, the utility of combined analysis of data from high-throughput proteomic screening with genome-wide analysis is exemplified in a segregating mouse cross with the identification of variation in Hba2 and Apoa2 underlying the most differentially regulated proteins. Even though both of the detailed examples given had mass differences in the protein, this method would seem equally sensitive to strong cis eQTLs that changed expression levels but not the mass of the protein. In contrast to previous work in tissue extracts of smaller cohorts of mice and yeast (Klose et al. 2002; Foss et al. 2007; Ghazalpour et al. 2011) , the current work used a rapid screening method for plasma. This allowed the analysis of a much larger number of animals from a complete segregating F2-intercross. We were also able to identify potential causal genetic variants of these traits.
The methodology used in the present work is rapid and highly suitable for highthroughput and large-scale studies. Moreover, we show that adequate standardization is possible, leading to coefficients of variation of measurements in the range of 20%. A clear limitation of the proteomic screening technology is the lack of direct identification of proteins (Pusch and Kostrzewa 2005) compared to other techniques such as quantitative mass spectrometry using differential isotope labelling or label free approaches which do allow protein identification (Gstaiger and Aebersold 2009 (Ghazalpour et al. 2011 ). An alterative approach for future studies might be targeted proteomics (Gstaiger and Aebersold 2009 ). This technique permits simultaneous analysis of a pre-specified set of proteins and is currently an area of intense research. In any case, proteomic technology might be still limited but ongoing developments clearly indicate significant progress.
The present study does not only provide proof of concept but also suggests the utility of plasma proteomic QTL mapping for any genetic study. Suitability for high-throughput analyses might make this approach particularly promising for large-scale human genome-wide association studies. Moreover, plasma is readily available in most of these cohorts. Once genetic variation of certain components of the proteome is detected, it might be followed up by more specific technologies such as MALDI TOF/TOF or LC-MS/MS with Orbitrap as exemplified in the present work.
In summary, results of the present work suggest an added value by the proposed combined analysis of genome-wide and proteome wide data, applicable to any hypothesis-free genetic study. Orbitrap Velos confirming expected sequence variants. *P < 0.05, ***P < 0.001.
